You would have to be #$%$ not to take some profits or sell completely after a 145% rise in stock price. You would also have to be , and I will use a more appropriate word .... crazy...crazy to short this stock when the float is so small. All the better if no one agreess with me. Just watch how fast your paper profits will disapper.
I think the FDA will say eluxadoline is too hard on the pancreas, and will need more study. The pancreas is a very critical organ and one of the hardest to treat for disease. The risk will be too high. The pancreas is an endocrine gland producing several important hormones including insulin, glucagon, somatostatin, and pancreatic polypeptide which circulate in the blood.
An insider just sold $13 million dollars worth of stock.
Because the float is so small you should not short this stock, the upside is also small and FORX will report a fair size loss on March 11th. . If the drug gets approved which is not likely, then it will not be on the market until late 2106 , perhaps more like 2017.
Put your money somewhere else, there are alot more other companies that will offer you a better return with a lot less risk.
If you are in the money with this stock you should take it.
Good luck, nobody like to loose money. Approval not likely for eluxadoline.
....either way this is not good for UPS and at an all time high it makes it an even worse time to buy, which can only mean one thing, it is time to sell and maybe buy back later....this is going to cost UPS no matter how you look at it....a good time to sell at this high level.